The Association of High Red Blood Cell Distribution Width with Metabolic Syndrome in Stable Coronary Artery Disease

Özet

Introduction: Metabolic syndrome (MetS) increases the risk of cardiovascular diseases. The value of red blood cell width (RDW ) has been demonstrated in several studies in coronary artery disease. This study aims to investigate the significance of RDW in MetS patients with coronary artery disease (CAD).Methods: In this study, 120 of 89 patients undergoing coronary angiography were included. The whole group was divided into two groups according to coronary stenosis as noncritical and critical CAD. The study group was also divided into MetS and non-MetS. The cardiometabolic risk parameters were evaluated and RDW was calculated from complete blood count.Results: MetS prevalence was not significantly different between critic (71%) and noncritical CAD (59.5%) groups. RDW was significantly associated with MetS in the whole study population (p=0.037) and was significantly higher in the critic-CAD-MetS group (p=0.018).Discussion and Conclusion: RDW is an inflammation marker that is associated with MetS patients in CAD. The higher value of RDW is associated with critic-CAD. Future studies are needed to demonstrate the role of RDW on MetS to predict long-term cardiovascular events.